First-in-Human Transapical Beating-Heart Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy.
Jing FangYani LiuYing ZhuRui LiRui WangDao Wen WangYunhu SongChenhe LiYue ChenLin ChengKangchao ZhengYun ZhaoShiliang LiCai ChengLiming XiaXiaoping ChenSong WanXiang WeiPublished in: Journal of the American College of Cardiology (2023)
TA-BSM is a safe and efficient minimally invasive procedure for septal reduction of heterogeneous HOCM. Compared with conventional septal myectomy, TA-BSM provides real-time evaluation to guide resection while reducing surgical trauma. (Transapical Beating-Heart Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy; NCT05332691).
Keyphrases
- hypertrophic cardiomyopathy
- left ventricular
- heart failure
- minimally invasive
- mitral valve
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- endothelial cells
- atrial fibrillation
- aortic stenosis
- induced pluripotent stem cells
- coronary artery disease
- pluripotent stem cells
- trauma patients